Is it worth patenting your AI tools for drug discovery?
Often, when the AI identifies a drug, and experiments confirm it is useful for the intended purpose, the drug can be patented. But what about the AI itself – can the AI be protected by patents, and should you try to?
Real-world rules apply to patenting computer simulations
It is possible to patent computer-implemented inventions at the European Patent Office (EPO). In particular, it is possible to patent computer-implemented inventions (CIIs) which function in the real-world.
Tech transfer teams’ IP challenges post-COVID-19 and beyond: part three how much data is enough in biotech and pharma patents applications?
‘Tech transfer teams’ IP challenges post-COVID-19 and beyond’ is a series of interactive virtual discussions,
CRISPR: An update
What is CRISPR? Clustered regularly interspaced short palindromic repeats (CRISPRs) are a family of DNA
Drug repurposing to treat COVID-19 – practical, legal and moral implications where research involves patent-protected drugs
One of the big talking points at present is how we can get back to
Akebia and Fibrogen – Lord Justice Arnold applies “Doctrine of Equivalents”
In this judgment at the High Court, Lord Justice Arnold stepped down from the Court